SRD5A1

Across TCGA pan-cancer cohorts, SRD5A1 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SRD5A1’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where SRD5A1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SRD5A1 is over-expressed in tumor.

LSCC and LUAD are the cancer types where SRD5A1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SRD5A1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	All	III,IV	+1.913	<.001	9	view →
LUAD	Male	II,III,IV	+2.133	<.001	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

SRD5A1–LSCC

Open the LSCC breakdown →